Skip to main content
Clinical Trials/JPRN-UMIN000031111
JPRN-UMIN000031111
Completed
Phase 4

The efficacy of progestin primed ovarian stimulation (PPOS) during controlled ovarian stimulation(COS) for patients with endometriosis - PPOS for patients with endometriosis

Kamiya Ladies Clinic0 sites150 target enrollmentFebruary 5, 2018
Conditionsinfertility

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
infertility
Sponsor
Kamiya Ladies Clinic
Enrollment
150
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

During this study, no premature LH surge was detected. A smaller number of oocytes were retrieved in the dienogest(DNG) group than in the dydrogesterone(DYG) group (6.18 vs. 9.85); however, the rate of mature oocytes was significantly higher in the DNG group than in the DYG group (89.1% vs. 78.9%). The fertilization rate was comparable between two groups. Therefore, patients taking DNG for PPOS can continue endometriosis treatment and obtain good-quality embryos during COH.

Registry
who.int
Start Date
February 5, 2018
End Date
December 31, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients who documented cycles with no oocyte retrieved, any contraindications to ovarian stimulation treatment and 2\) patients who has contraindication to DNG, GnRHa, EP, FSH, HMG, HCG 3\) Patients who is judged to be inappropriate for this study by the doctor

Outcomes

Primary Outcomes

Not specified

Similar Trials